IL1B and Alzheimer disease: This is evidenced by elevated levels of various inflammatory mediators, including nuclear factor-kappa B (NF-κB), tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) in individuals with AD [36].